| Stage | ELAN | % of rev | LLY | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.4B | 100.00% | $24.4B | 100.00% | LLY ×17.83 |
| Gross profit | $798M | 58.33% | $20.5B | 83.88% | LLY +25.5pp |
| Operating income | $115M | 8.41% | $8.6B | 35.28% | LLY +26.9pp |
| Pre-tax income | $56M | 4.09% | $8.4B | 34.46% | LLY +30.4pp |
| Net income | $54M | 3.95% | $6.5B | 26.44% | LLY +22.5pp |
| Stage | ELAN | LLY | Gap · A − B |
|---|---|---|---|
| Revenue | $1.4B100.00% | $24.4B100.00% | LLY ×17.83 |
| Gross profit | 58.33%$798M | 83.88%$20.5B | LLY +25.5pp |
| Operating income | 8.41%$115M | 35.28%$8.6B | LLY +26.9pp |
| Pre-tax income | 4.09%$56M | 34.46%$8.4B | LLY +30.4pp |
| Net income |
| 3.95%$54M |
| 26.44%$6.5B |
| LLY +22.5pp |
No shared counterparties.